Safety results
pre‐dose
EVENTS
In total, on‐treatment AEs were reported in 13 participants and post‐treatment AEs were reported in eight participants during the study (Table There were six reported clinical chemistry‐related AEs (ALT increased >33 IU/L and aspartate aminotransferase [AST] increased >32 IU/L) either pre‐dose or during the study. All events were reported as mild intensity, and the events were considered as not related to the study medication by the investigator.There was a serious quality issue identified during the study, which was reported for investigation to the institutional review board. The investigation showed no impact of any clinical significance for any participants; further details can be found in the Supporting Information.